TargetTau-1 Study
Are you or someone you know showing early symptoms of memory loss (mild cognitive impairment) or early Alzheimer’s disease? Common early symptoms include:
-
Loss of memory that affects daily living
-
Poor judgement that leads to bad decision making
-
Difficulty completing familiar tasks
-
Repeating questions or forgetting recently learnt information
-
Losing track of dates or locations; losing things and having trouble retracing steps
-
Trouble understanding visual images, resulting in difficulty reading or driving
-
Changes in mood and personality
None of these are enough by themselves to make a diagnosis, but experiencing several of them could be cause for your doctor to investigate further.
If you are someone you know are experiencing any of these symptoms, ask your doctor about Alzheimer’s disease and the TargetTau-1 Study testing a new, investigational medicine for mild cognitive impairment or early Alzheimer’s disease.
The purpose of this study is to learn more about an investigational drug called BMS-986446 to see if could be used to safely and effectively treat mild cognitive impairment due to Alzheimer’s disease, or mild Alzheimer’s dementia. It will also test its effects on memory, thinking, and daily functioning.
To learn more about this Alzheimer’s disease clinical study, visit: bmsclinicaltrials.com/
Or email ResearchNCNE@myneurodr.com / call 781-551-5812 opt.2.